1. Home
  2. CYBN vs WBX Comparison

CYBN vs WBX Comparison

Compare CYBN & WBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYBN
  • WBX
  • Stock Information
  • Founded
  • CYBN 2019
  • WBX 2015
  • Country
  • CYBN Canada
  • WBX Spain
  • Employees
  • CYBN N/A
  • WBX N/A
  • Industry
  • CYBN Pharmaceuticals and Biotechnology
  • WBX Industrial Specialties
  • Sector
  • CYBN Health Care
  • WBX Consumer Discretionary
  • Exchange
  • CYBN Nasdaq
  • WBX Nasdaq
  • Market Cap
  • CYBN 147.4M
  • WBX 118.0M
  • IPO Year
  • CYBN N/A
  • WBX N/A
  • Fundamental
  • Price
  • CYBN $5.66
  • WBX $3.00
  • Analyst Decision
  • CYBN Strong Buy
  • WBX Buy
  • Analyst Count
  • CYBN 4
  • WBX 4
  • Target Price
  • CYBN $71.25
  • WBX $9.50
  • AVG Volume (30 Days)
  • CYBN 1.2M
  • WBX 26.9K
  • Earning Date
  • CYBN 11-13-2025
  • WBX 11-05-2025
  • Dividend Yield
  • CYBN N/A
  • WBX N/A
  • EPS Growth
  • CYBN N/A
  • WBX N/A
  • EPS
  • CYBN N/A
  • WBX N/A
  • Revenue
  • CYBN N/A
  • WBX $174,593,453.00
  • Revenue This Year
  • CYBN N/A
  • WBX N/A
  • Revenue Next Year
  • CYBN N/A
  • WBX $46.25
  • P/E Ratio
  • CYBN N/A
  • WBX N/A
  • Revenue Growth
  • CYBN N/A
  • WBX N/A
  • 52 Week Low
  • CYBN $4.81
  • WBX $2.85
  • 52 Week High
  • CYBN $11.39
  • WBX $14.96
  • Technical
  • Relative Strength Index (RSI)
  • CYBN 41.21
  • WBX 19.33
  • Support Level
  • CYBN $5.52
  • WBX $2.85
  • Resistance Level
  • CYBN $6.30
  • WBX $3.47
  • Average True Range (ATR)
  • CYBN 0.32
  • WBX 0.30
  • MACD
  • CYBN -0.07
  • WBX -0.07
  • Stochastic Oscillator
  • CYBN 19.61
  • WBX 9.66

About CYBN Cybin Inc.

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.

About WBX Wallbox N.V.

Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.

Share on Social Networks: